Dinesh Kumar Thirugnanam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dinesh Kumar Thirugnanam has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Dheeravath Raju
Centre for Multidisciplinary Research, Anurag University, Hyderabad, Telangana, India
1 shared publication - Dukhbhanjan Singh
Centre of Research Impact and Outcome, Chitkara University, Rajpura- 140417, Punjab, India
1 shared publication - Karthikeyan Kaliyamurthi
Medical Oncology, Mahatma Gandhi medical college and Research Institute, Sri balaji Vidyapeeth University, Pondicherry, Puducherry, India
1 shared publication - Priyanka Samal
Department of Haematology, IMS and SUM Hospital, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India
1 shared publication - Shivam Khurana
Chitkara Centre for Research and Development, Chitkara University, Himachal Pradesh-174103 India
1 shared publication
Latest Publications
- Open Access
- 9 August 2025
- Published by Salud, Ciencia y Tecnologia in Health Leadership and Quality of Life
- Vol. 4, 642
Impact of Emotional and Psychological Issues on Hematologic Cancer Patients Undergoing Stem-Cell Transplants
Hematopoietic stem cell transplant (HSCT) morbidity has decreased in recent decades owing to improvement in post-transplant concern with transplantation therapy. However, psychological discomfort is common among HSCT patients, and it can have a detrimental effect on function, recovery, and health outcomes, including an increased risk of implant with host illness and mortality. Several improved health outcomes and increased treatment participation are the results of properly diagnosing and treating these psychological problems. The principle of the investigation is to observe the psychological and emotional challenges that recipients of stem-cell transplants who have hematologic malignancies face. It aims to assess how these issues affect patients' overall quality of life (QoL), persistence in treatments, and recovery outcomes. For the examination, 70 people with Hematologic cancer of HSCT were considered, to analyze the emotional and psychological issues within the patients during their stay in the hospital. Statistical Package for Social Sciences (SPSS) was analyzed and the findings show that the research used methods such as the paired t-test, Wilcoxon Signed-Rank Test and Regression analysis. Anxiety levels decreased from 28.6% to 14.3% and depression levels from 21.4% to 14.3%, respectively, following SCT, based on the analysis.
- 9 August 2025
- Published by Salud, Ciencia y Tecnologia in Health Leadership and Quality of Life
- Vol. 4, 642
Open AccessImpact of Emotional and Psychological Issues on Hematologic Cancer Patients Undergoing Stem-Cell Transplants
Hematopoietic stem cell transplant (HSCT) morbidity has decreased in recent decades owing to improvement in post-transplant concern with transplantation therapy. However, psychological discomfort is common among HSCT patients, and it can have a detrimental effect on function, recovery, and health outcomes, including an increased risk of implant with host illness and mortality. Several improved health outcomes and increased treatment participation are the results of properly diagnosing and treating these psychological problems. The principle of the investigation is to observe the psychological and emotional challenges that recipients of stem-cell transplants who have hematologic malignancies face. It aims to assess how these issues affect patients' overall quality of life (QoL), persistence in treatments, and recovery outcomes. For the examination, 70 people with Hematologic cancer of HSCT were considered, to analyze the emotional and psychological issues within the patients during their stay in the hospital. Statistical Package for Social Sciences (SPSS) was analyzed and the findings show that the research used methods such as the paired t-test, Wilcoxon Signed-Rank Test and Regression analysis. Anxiety levels decreased from 28.6% to 14.3% and depression levels from 21.4% to 14.3%, respectively, following SCT, based on the analysis.